Evidence map›Paper›PMID 35181608›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Reversible dougong structured receptor-ligand recognition for building dynamic extracellular matrix mimics.

Wenbo He, Jiaxiang Bai, Xu Chen, Di Suo, Shenghao Wang, Qianping Guo, Weiling Yin, Dechun Geng, Miao Wang, Guoqing Pan and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Wenbo HeInstitute for Advanced Materials, School of Materials Science and Engineering, Jiangsu University, Zhenjiang 212013, China.
Jiaxiang BaiDepartment of Orthopaedic Surgery, Orthopedic Institute, The First Affiliated Hospital, Suzhou Medical College, Soochow University, Suzhou 215006, China.ORCID 0000-0002-3485-5563
Xu ChenInstitute for Advanced Materials, School of Materials Science and Engineering, Jiangsu University, Zhenjiang 212013, China.
Di SuoDepartment of Biomedical Engineering, The Hong Kong Polytechnic University, Hung Hom 999077, Hong Kong, China.
Shenghao WangDepartment of Orthopaedic Surgery, Orthopedic Institute, The First Affiliated Hospital, Suzhou Medical College, Soochow University, Suzhou 215006, China.ORCID 0000-0003-0595-5845
Qianping GuoDepartment of Orthopaedic Surgery, Orthopedic Institute, The First Affiliated Hospital, Suzhou Medical College, Soochow University, Suzhou 215006, China.
Weiling YinInstitute for Advanced Materials, School of Materials Science and Engineering, Jiangsu University, Zhenjiang 212013, China.
Dechun GengDepartment of Orthopaedic Surgery, Orthopedic Institute, The First Affiliated Hospital, Suzhou Medical College, Soochow University, Suzhou 215006, China.ORCID 0000-0003-1425-2535
Miao WangInstitute for Advanced Materials, School of Materials Science and Engineering, Jiangsu University, Zhenjiang 212013, China.
Guoqing PanInstitute for Advanced Materials, School of Materials Science and Engineering, Jiangsu University, Zhenjiang 212013, China; panguoqing@ujs.edu.cn xin.zhao@polyu.edu.hk binli@suda.edu.cn.ORCID 0000-0001-5187-796X
Xin ZhaoDepartment of Biomedical Engineering, The Hong Kong Polytechnic University, Hung Hom 999077, Hong Kong, China; panguoqing@ujs.edu.cn xin.zhao@polyu.edu.hk binli@suda.edu.cn.ORCID 0000-0002-9521-7768
Bin LiDepartment of Orthopaedic Surgery, Orthopedic Institute, The First Affiliated Hospital, Suzhou Medical College, Soochow University, Suzhou 215006, China; panguoqing@ujs.edu.cn xin.zhao@polyu.edu.hk binli@suda.edu.cn.
Jiangsu University · CNSoochow University · CNHong Kong Polytechnic University · HKNantong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dynamic biomaterials excel at recapitulating the reversible interlocking and remoldable structure of the extracellular matrix (ECM), particularly in manipulating cell behaviors and adapting to tissue morphogenesis. While strategies based on dynamic chemistries have been extensively studied for ECM-mimicking dynamic biomaterials, biocompatible molecular means with biogenicity are still rare. Here, we report a nature-derived strategy for fabrication of dynamic biointerface as well as a three-dimensional (3D) hydrogel structure based on reversible receptor-ligand interaction between the glycopeptide antibiotic vancomycin and dipeptide d-Ala-d-Ala. We demonstrate the reversible regulation of multiple cell types with the dynamic biointerface and successfully implement the dynamic hydrogel as a functional antibacterial 3D scaffold to treat tissue repair. In view of the biogenicity and high applicability, this nature-derived reversible molecular strategy will bring opportunities for malleable biomaterial design with great potential in biomedicine.

Indexed as

AlanineBiocompatible MaterialsBiomimeticsDipeptidesExtracellular MatrixHumansHydrogelsLigandsProtein EngineeringVancomycinAlanineBiocompatible MaterialsDipeptidesHydrogelsLigandsVancomycinbiomimicrycell regulationdynamic biomaterial designnatural receptor–ligand interactiontissue repair

Identifiers

PMID35181608
PMCPMC8872741
OpenAlexW4213275922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.